CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- SCHEDULE 13D Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Exit or restructuring costs · Impairment · Executive or director change · Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 5 of 29 · 576 filings